January 2005
Taber's Cyclopedic Medical Dictionary;2005, p2059
Reference Entry
A definition of the abbreviation "SSRI" is presented. It refers to selective serotonin reuptake inhibitor.


Related Articles

  • paroxetine.  // Taber's Cyclopedic Medical Dictionary;2005, p1600 

    A definition of the medical term "paroxetine" is presented. Paroxetine refers to a selective serotonin reuptake inhibitor used as an antianxiety agent and antidepressant. It is administered orally to manage depression, panic, obsessive-compulsive disorder, social anxiety and general anxiety. It...

  • 5-HT1A/1B Receptor-Mediated Effects of the Selective Serotonin Reuptake Inhibitor, Citalopram, on Sleep: Studies in 5-HT1A and 5-HT1B Knockout Mice. Monaca, Christelle; Boutrel, Benjamin; Hen, René; Hamon, Michel; Adrien, Joëlle // Neuropsychopharmacology;May2003, Vol. 28 Issue 5, p850 

    Selective serotonin reuptake inhibitors (SSRIs) are extensively used for the treatment of depression. Aside from their antidepressant properties, they provoke a deficit in paradoxical sleep (PS) that is most probably mediated by the transporter blockade-induced increase in serotonin...

  • Escitalopram continuation treatment prevents relapse of depressive episodes.  // Current Medical Literature: Psychiatry;2004, Vol. 15 Issue 2, p39 

    Discusses research being done on escitalopram isomer selective serotonin reuptake inhibitor. Reference to a study by M. H. Rapaport, A. Bose and H. Zheng, published in the 2004 issue of the "Journal of Clinical Psychiatry"; Comparison between escitalopram and citalopram; Profile of patients who...

  • Placebo-Controlled Trial Comparing Intermittent and Continuous Paroxetine in Premenstrual Dysphoric Disorder. Landén, Mikael; Nissbrandt, Hans; Allgulander, Christer; Särvik, Karin; Ysander, Christina; Eriksson, Elias // Neuropsychopharmacology;Jan2007, Vol. 32 Issue 1, p153 

    Serotonin reuptake inhibitors (SRIs) do not have to be administered continuously to be effective for premenstrual dysphoric disorder (PMDD), but can be given during luteal phases only. This is of practical importance, but also of theoretical interest since it suggests that the onset of action of...

  • A Single Dose of the Selective Serotonin Reuptake Inhibitor Citalopram Exacerbates Anxiety in Humans: A Fear-Potentiated Startle Study. Grillon, Christian; Levenson, Jessica; Pine, Daniel S. // Neuropsychopharmacology;Jan2007, Vol. 32 Issue 1, p225 

    Serotonin reuptake inhibitors may increase symptoms of anxiety immediately following treatment initiation. The present study examined whether acute citalopram increased fear-potentiated startle to predictable and/or unpredictable shocks in healthy subjects. Eighteen healthy subjects each...

  • Review: selective serotonin reuptake inhibitors as effective as tricyclic antidepressants for major depression, and may have fewer adverse effects. Cipriani Andrea // Evidence Based Mental Health;Nov2003, Vol. 6 Issue 4, p117 

    Assesses the effectiveness and safety of selective serotonin reuptake inhibitors compared with tricyclic antidepressant in people with depression treated in primary care. Results showing that severity of depression varied among participants and that selective serotonin reuptake inhibitors and...

  • Citalopram concentrations and response in obsessive-compulsive disorder. Preliminary results. Bareggi, Silvio R.; Bianchi, L.; Cavallaro, R.; Gervasoni, M.; Siliprandi, F.; Bellodi, L. // CNS Drugs;2004, Vol. 18 Issue 5, p329 

    Objective: Citalopram, a highly potent SSRI, is effective in the treatment of depressive disorders and obsessive-compulsive disorder (OCD); however, very few studies have reported concentration-effect relationships for SSRIs. The aim of this study was to investigate the relationship...

  • Association of Citalopram with Deaths in Northern Ontario: Comparison of Cases with the Literature.  // Journal of Analytical Toxicology;May/Jun2004, Vol. 28 Issue 4, p301 

    Presents the abstract of the study "Association of Citalopram with Deaths in Northern Ontario: Comparison of Cases with the Literature," by James W. Rajotte and Randy J. Warren.

  • Acute 5-HT Reuptake Blockade Potentiates Human Amygdala Reactivity. Bigos, Kristin L.; Pollock, Bruce G.; Aizenstein, Howard J.; Fisher, Patrick M.; Bies, Robert R.; Hariri, Ahmad R. // Neuropsychopharmacology;Dec2008, Vol. 33 Issue 13, p3221 

    Variability in serotonin (5-HT) function is associated with individual differences in normal mood and temperament, as well as psychiatric illnesses, all of which are influenced by amygdala function. This study evaluated the acute effects of 5-HT reuptake blockade on amygdala function using...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics